All community pharmacy articles
-
PHE/DH/DWP guidelinePHE COVID-19 infection prevention and control guidance
Summary of the latest UK guidance on infection prevention and control measures for COVID-19
-
NHS guideline
NHS hepatitis C antibody testing guidance for community pharmacy
Summarised information on offering HCV antibody testing in community pharmacy
-
NICE guideline
COVID-19 rapid guideline on gastrointestinal and liver conditions affecting immune response
A summary of guidance intended to maximise the safety of children and adults with gastrointestinal or liver conditions treated with drugs affecting the immune response during the COVID-19 pandemic
-
NICE guideline
COVID-19 guideline on rheumatological autoimmune, inflammatory, and metabolic bone disorders
This guideline aims to maximise the safety of children and adults with rheumatological autoimmune, inflammatory, and metabolic bone disorders during the COVID-19 pandemic
-
NICE guideline
NICE CKS on chickenpox
Management of chickenpox in healthy children and adults, during pregnancy and breastfeeding, and in people who are immunocompromised
-
NICE guideline
NICE CKS on common cold
A useful summary for community pharmacists covering diagnosis, management, and prescribing information in adults, children, and young people
-
PHE/DH/DWP guideline
PHE COVID-19 vaccination guidance
A concise summary of guidance for healthcare professionals about the COVID-19 vaccination programme
-
Independent professional body guideline
HEART UK Managing hyperlipidaemia and COVID-19
A summary of collated current evidence surrounding the safety of lipid-lowering medications in patients who have COVID-19
-
NICE guideline
NICE CKS on rosacea
A summary of guidance to assist healthcare professionals on the diagnosis and management of rosacea
-
PHE/DH/DWP guideline
PHE management of patient/staff exposure to COVID-19
This summary provides guidance on the management of staff and patients according to exposures, symptoms, and test results
-
News
PHE publishes new guidance on managing COVID-19 variants of concern
Amid concerns around the spread of new COVID-19 variants, PHE has published guidance for identifying and managing possible or confirmed cases
-
PHE/DH/DWP guideline
NHS England COVID-19 vaccination SOP
This standard operating procedure (SOP) summary describes the operating model and design requirements for safe delivery of COVID-19 vaccines in the community
-
News
UK government publishes largest ever vaccination delivery plan
The British government has set out a plan that aims to vaccinate millions of people against COVID-19 by the spring
-
NICE guideline
NICE CKS on constipation
Areas covered in the summary include: advice for those with the condition, management (short-duration and chronic), secondary causes of the condition, and prescribing information
-
News
Moderna COVID-19 vaccine approved by MHRA
The Moderna vaccine has become the third COVID-19 vaccine—and the second mRNA COVID-19 vaccine—to be approved for use in the UK
-
NICE guideline
NICE ‘long COVID’ guideline
Recommendations for identifying and managing ‘long-COVID’ in primary care
-
PHE/DH/DWP guideline
PHE influenza immunisation 2020/21 guideline
This Guidelines summary covers key information on expansion of the 2020-21 flu immunisation programme.
-
NICE guideline
NICE guideline on the treatment of human and animal bites
This NICE guideline summary sets out an antimicrobial prescribing strategy for human and animal bites (excluding insect bites) in adults, young people and children aged 72 hours and over
-
PHE/DH/DWP guideline
PHE UTI guideline
A brief guide to the diagnosis and management of UTIs in primary care, which includes clear algorithms for the assessment of urinary symptoms.
-
NHS guideline
NHS England COVID-19 guidance for community pharmacy
This standard operating procedure summary sets out general principles for the delivery of services during the COVID-19 pandemic, and requires local interpretation
